Ftse Mib
34.650,95
0,91%
DAX
18.772,85
0,50%
S&P 500
5.221,20
0,14%
NASDAQ
16.335,13
-0,07%
Bitcoin
60.262,63
-4,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adicet Bio Inc (ACET) Adicet Bio Inc (ACET) Notizie

ACET

Adicet Bio (ACET)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET
DataOraFonteTitoloSimboloCompagnia
10/05/202412:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
07/05/202413:00Business WireAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
30/04/202423:10Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
22/04/202422:30Business WireAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/04/202413:00Business WireAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
19/03/202421:10Business WireAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
11/03/202412:00Business WireAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
05/02/202422:01Business WireAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:ACETAdicet Bio Inc
02/02/202417:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACETAdicet Bio Inc
27/01/202401:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
25/01/202422:01Business WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
24/01/202422:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
23/01/202405:43Business WireAdicet Bio, Inc. Announces Pricing of Public OfferingNASDAQ:ACETAdicet Bio Inc
22/01/202422:28Business WireAdicet Bio, Inc. Announces Proposed Public OfferingNASDAQ:ACETAdicet Bio Inc
19/01/202422:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACETAdicet Bio Inc
04/01/202413:00Business WireAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024NASDAQ:ACETAdicet Bio Inc
03/01/202422:01Business WireAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate OutlookNASDAQ:ACETAdicet Bio Inc
10/12/202318:00Business WireAdicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/11/202322:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
08/11/202322:10Business WireAdicet Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
07/11/202313:00Business WireAdicet Bio to Present at the 2023 Jefferies London Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
02/11/202314:00Business WireAdicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
04/10/202318:00Business WireAdicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics ConferenceNASDAQ:ACETAdicet Bio Inc
29/09/202323:24Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
27/09/202315:00Business WireAdicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:ACETAdicet Bio Inc
09/08/202322:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ACETAdicet Bio Inc
09/08/202322:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACETAdicet Bio Inc
09/08/202322:15Business WireAdicet Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
02/08/202322:00Business WireAdicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:ACETAdicet Bio Inc
11/07/202322:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACET

La tua Cronologia

BIT
P1YDF4
NLBNPIT1YDF4 20240621 30
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network